23,338,039
Vote Records
27,979
Companies
11,817
Funds
4,051
Managers

Home › Companies › Insmed Incorporated › 2025-2026

Insmed Incorporated 2025-2026 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and Insmed Incorporated’s Form 8-K, filed May 15, 2026 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 4Ballot items
  • 638Asset managers, any item
  • 3,740Fund votes
  • May 13, 2026Meeting date

Results at a glance

Meeting of May 13, 2026: 4 items on Insmed Incorporated’s Form 8-K, filed May 15, 2026: 2 approved · 2 passed (calculated).

Dissent

Notable dissent: 2 directors (17.3%, 11.5% against).

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Insmed Incorporated in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Insmed Incorporated

These tallies are Insmed Incorporated’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 15, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Insmed Incorporated — official shareholder meeting results, meeting held May 13, 2026
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Elizabeth McKee Anderson 153,734,471---- 32,130,98011,564,082 83%Passed (calculated)—
Elect Director: Clarissa Desjardins, Ph.D. 164,437,828---- 21,427,62311,564,082 88%Passed (calculated)—
2. Advisory Vote on the 2025 Compensation of Named Executive Officers 162,133,72823,657,32574,398 --11,564,082 87%Approved—
3. Ratification of the Appointment of an Independent Registered Public Accounting Firm 190,386,6126,997,61345,308 ---- 96%Approved—

Source: Insmed Incorporated, Form 8-K, filed with the SEC on May 15, 2026 — read the filing on EDGAR.

How asset managers voted at the Insmed Incorporated 2025-2026 meeting

638 asset managers disclosed a vote on at least one Insmed Incorporated item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.

Elect Director: Clarissa Desjardins, Ph.D.

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 12 wordings of this item as funds reported it.

88% Majority: yes · of votes cast

FOR 88%
FOR: 164,437,828WITHHELD: 21,427,623
Details: description as filed, official tally, votes by 156 asset managers

Description as filed by funds: Election of two Class II directors, Elizabeth McKee Anderson and Clarissa Desjardins, Ph.D. to serve until the 2029 Annual Meeting of Shareholders: Clarissa Desjardins, Ph.D.

Insmed Incorporated’s own tally for this item (“Elect Director: Clarissa Desjardins, Ph.D.”): 164,437,828 for, 21,427,623 withheld, per its Form 8-K filed May 15, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 88% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 156 asset managers below reported 83,968,115 for, 2,847,814 withheld, 17,266 abstained, 163 not voted.

FOR
FOR: 83,968,115ABSTAIN: 17,266WITHHOLD: 2,847,814NOT VOTED: 163
Largest asset managers voting on “Election of two Class II directors, Elizabeth McKee Anderson and Clarissa Desjardins, Ph.D. to serve until the” at Insmed Incorporated, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard20,079,7620 900For
JPMorgan14,732,0120 00For
Fidelity13,606,0000 00For
Invesco6,247,1570 00For
BlackRock5,850,8070 00For
Capital Group4,716,3970 00For
T. Rowe Price00 02,221,489Withhold
Columbia Threadneedle1,946,8850 00For
Charles Schwab1,013,4920 00For
Franklin Custodian Funds850,0000 00For
Bridge Builder Trust777,1960 00For
FRANKLIN STRATEGIC SERIES687,8310 00For
American Century680,5420 00For
Waddell & Reed657,2720 00For
Jackson National650,1880 00For
State Street606,3480 00For
MUTUAL FUND SERIES TRUST551,3280 00For
Victory Capital519,5780 00For
Equitable327,1720 0178,413Mixed
CARILLON SERIES TRUST500,9530 00For
TIAA471,7030 00For
Lord Abbett452,2860 00For
Principal412,2850 00For
Federated Hermes374,5980 00For
Manager Directed Portfolios352,5310 00For

Showing the 25 largest of 156 asset managers. All 156 are in the interactive database (link above).

Elect Director: Elizabeth McKee Anderson

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 13 wordings of this item as funds reported it.

83% Majority: yes · of votes cast

FOR 83%WITHHELD
FOR: 153,734,471WITHHELD: 32,130,980
Details: description as filed, official tally, votes by 156 asset managers

Description as filed by funds: Election of two Class II directors, Elizabeth McKee Anderson and Clarissa Desjardins, Ph.D. to serve until the 2029 Annual Meeting of Shareholders: Elizabeth McKee Anderson

Insmed Incorporated’s own tally for this item (“Elect Director: Elizabeth McKee Anderson”): 153,734,471 for, 32,130,980 withheld, per its Form 8-K filed May 15, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 83% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 156 asset managers below reported 82,987,900 for, 3,760,272 withheld, 85,023 abstained, 163 not voted.

FOR
FOR: 82,987,900ABSTAIN: 85,023WITHHOLD: 3,760,272NOT VOTED: 163
Largest asset managers voting on “Election of two Class II directors, Elizabeth McKee Anderson and Clarissa Desjardins, Ph.D. to serve until the” at Insmed Incorporated, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard20,062,8330 12816,891For
JPMorgan14,732,0120 00For
Fidelity13,606,0000 00For
Invesco6,247,1570 00For
BlackRock5,850,8070 00For
Capital Group4,716,3970 00For
T. Rowe Price00 02,221,489Withhold
Columbia Threadneedle1,946,8850 00For
Charles Schwab1,013,4920 00For
Franklin Custodian Funds850,0000 00For
Bridge Builder Trust777,1960 00For
FRANKLIN STRATEGIC SERIES687,8310 00For
American Century680,5420 00For
Waddell & Reed657,2720 00For
Jackson National647,7650 2,4230For
State Street1,7520 0604,596Withhold
MUTUAL FUND SERIES TRUST551,3280 00For
Victory Capital519,5780 00For
Equitable327,1720 0178,413Mixed
CARILLON SERIES TRUST500,9530 00For
TIAA471,7030 00For
Lord Abbett452,2860 00For
Principal412,2850 00For
Federated Hermes374,5980 00For
Manager Directed Portfolios352,5310 00For

Showing the 25 largest of 156 asset managers. All 156 are in the interactive database (link above).

Advisory Vote on the 2025 Compensation of Named Executive Officers

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 10 wordings of this item as funds reported it.

87% Approved · of votes cast

FOR 87%
FOR: 162,133,728AGAINST: 23,657,325

Prior year: 96.6% for (May 15, 2025 meeting) ▼ 9.3 pts

Details: description as filed, official tally, votes by 637 asset managers

Description as filed by funds: An advisory vote on the 2025 compensation of our named executive officers.

Insmed Incorporated’s own tally for this item (“2. Advisory Vote on the 2025 Compensation of Named Executive Officers”): 162,133,728 for, 23,657,325 against — passed, per its Form 8-K filed May 15, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “By the following vote, shareholders approved, on an advisory, non-binding basis, the 2025 compensation of our named executive officers, as disclosed in the Proxy Statement:”
Support: 87% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 153 asset managers voting on “An advisory vote on the 2025 compensation of our named executive officers.” at Insmed Incorporated, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard20,079,75596 00For
JPMorgan14,732,0120 00For
Fidelity13,606,0000 00For
Invesco6,247,1570 00For
BlackRock5,850,8070 00For
Capital Group4,716,3970 00For
T. Rowe Price1,930,814290,675 00Mixed
Columbia Threadneedle1,946,8850 00For
Charles Schwab1,013,4920 00For
Franklin Custodian Funds850,0000 00For
Bridge Builder Trust777,1960 00For
FRANKLIN STRATEGIC SERIES687,8310 00For
American Century680,5420 00For
Waddell & Reed657,2720 00For
Jackson National650,1880 00For
State Street606,3480 00For
MUTUAL FUND SERIES TRUST551,3280 00For
Victory Capital519,5780 00For
Equitable505,5850 00For
CARILLON SERIES TRUST500,9530 00For
TIAA471,7030 00For
Lord Abbett452,2860 00For
Principal412,2850 00For
Federated Hermes374,5980 00For
Manager Directed Portfolios352,5310 00For

Fund voting reports, all 153 managers: 86,403,643 for, 404,274 against, 6,647 abstained, 163 not voted. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 521 asset managers voting on “An advisory vote on the 2025 compensation of our named executive officers.” at Insmed Incorporated, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Darwin Global Management, Ltd.017,163,874 00Against
Fidelity12,368,145703,849 00Mixed
BlackRock7,746,88944 00For
Invesco7,051,5500 00For
Artisan5,369,4630 00For
RTW INVESTMENTS, LP4,842,8800 00For
Capital Group4,818,8970 00For
GEODE CAPITAL MANAGEMENT, LLC4,412,3700 00For
State Street4,374,9130 00For
T. Rowe Price2,978,517418,885 00Mixed
Orbis Allan Gray Ltd2,605,7820 00For
JPMorgan2,454,4710 00For
FRANKLIN ADVISERS INC2,400,0800 00For
DE Shaw1,720,0050 00For
Vanguard1,641,6330 00For
WESTFIELD CAPITAL MANAGEMENT CO LP1,176,5830 00For
Charles Schwab1,134,0430 00For
Northern Trust1,109,2670 00For
NOMURA INVESTMENT MANAGEMENT BUSINESS TRUST1,076,8130 00For
Duquesne Family Office LLC1,008,2660 00For
Amundi0992,373 00Against
Castle Hook Partners LP908,4520 00For
PICTET ASSET MANAGEMENT SA876,4660 00For
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC851,8550 00For
AMERIPRISE FINANCIAL INC799,2690 00For

Institutional-manager reports, all 521 managers: 101,987,993 for, 22,928,600 against, 5,583 abstained, 8,741 not voted. Showing the 25 largest; every one is in the interactive database (link above).

Ratification of the Appointment of an Independent Registered Public Accounting Firm

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 3 wordings of this item as funds reported it.

96% Approved · of votes cast

FOR 96%
FOR: 190,386,612AGAINST: 6,997,613

Prior year: 96.8% for (May 15, 2025 meeting) ▼ 0.3 pts

Details: description as filed, official tally, votes by 157 asset managers

Description as filed by funds: Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026.

Insmed Incorporated’s own tally for this item (“3. Ratification of the Appointment of an Independent Registered Public Accounting Firm”): 190,386,612 for, 6,997,613 against — passed, per its Form 8-K filed May 15, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “By the following vote, shareholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026:”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 157 asset managers below reported 86,579,980 for, 167,782 against, 6,647 abstained, 163 not voted.

FOR
FOR: 86,579,980AGAINST: 167,782ABSTAIN: 6,647NOT VOTED: 163
Largest asset managers voting on “Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for ” at Insmed Incorporated, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard20,062,93316,918 00For
JPMorgan14,732,0120 00For
Fidelity13,606,0000 00For
Invesco6,247,1570 00For
BlackRock5,850,8070 00For
Capital Group4,716,3970 00For
T. Rowe Price2,221,4890 00For
Columbia Threadneedle1,946,8850 00For
Charles Schwab1,013,4920 00For
Franklin Custodian Funds850,0000 00For
Bridge Builder Trust777,1960 00For
FRANKLIN STRATEGIC SERIES687,8310 00For
American Century680,5420 00For
Waddell & Reed657,2720 00For
Jackson National650,1880 00For
State Street606,32721 00For
MUTUAL FUND SERIES TRUST551,3280 00For
Victory Capital519,5780 00For
Equitable505,5850 00For
CARILLON SERIES TRUST500,9530 00For
TIAA471,7030 00For
Lord Abbett452,2860 00For
Principal412,2850 00For
Federated Hermes374,5980 00For
Manager Directed Portfolios352,5310 00For

Showing the 25 largest of 157 asset managers. All 157 are in the interactive database (link above).

Largest Insmed Incorporated shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 216,521,841 shares outstanding at the time of that meeting.

Fund voting reports: top Insmed Incorporated shareholders by shares voted on “An advisory vote on the 2025 compensation of our named executive officers.”, 2025-2026
#Asset manager % of shares outstanding
1Vanguard 9.27%
2JPMorgan 6.80%
3Fidelity 6.28%
4Invesco 2.89%
5BlackRock 2.70%
6Capital Group 2.18%
7T. Rowe Price 1.03%
8Columbia Threadneedle 0.90%
9Charles Schwab 0.47%
10Franklin Custodian Funds 0.39%
Institutional-manager reports: top Insmed Incorporated shareholders by shares voted on “An advisory vote on the 2025 compensation of our named executive officers.”, 2025-2026
#Asset manager % of shares outstanding
1Darwin Global Management, Ltd. 7.93%
2Fidelity 6.04%
3BlackRock 3.58%
4Invesco 3.26%
5Artisan 2.48%
6RTW INVESTMENTS, LP 2.24%
7Capital Group 2.23%
8GEODE CAPITAL MANAGEMENT, LLC 2.04%
9State Street 2.02%
10T. Rowe Price 1.57%

Reported Insmed Incorporated holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

Insmed Incorporated holdings and ownership disclosed for the 2025-2026 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
JPMorgan Chase24,150,499 11.15%Form 13F, quarter ended March 31, 2026
Vanguard Group21,076,344 9.73%Form 13F, quarter ended March 31, 2026
BlackRock16,678,146 7.70%Form 13F, quarter ended March 31, 2026
FMR (Fidelity)13,160,167 6.08%Form 13F, quarter ended March 31, 2026
Darwin Global Management, Ltd.6,431,163 2.97%Schedule 13G, filed August 14, 2026
D.E. Shaw5,642,725 2.61%Form 13F, quarter ended March 31, 2026
State Street5,551,699 2.56%Form 13F, quarter ended March 31, 2026
T. Rowe Price3,092,807 1.43%Form 13F, quarter ended March 31, 2026
Franklin Templeton2,617,251 1.21%Form 13F, quarter ended March 31, 2026

Percentages above are of 216,521,841 shares outstanding, as reported by Insmed Incorporated on its Form 10-Q dated March 31, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At Insmed Incorporated's shareholder meeting held May 13, 2026, in the 2025-2026 proxy season, 638 asset managers reported votes on at least one of its 4 ballot items in their SEC Form N-PX filings, covering 3,740 separate fund positions. On the most widely held item on that ballot — An advisory vote on the 2025 compensation of our named executive officers. — Insmed Incorporated's filing reports the proposal as approved, with 87% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Insmed Incorporated's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 15, 2026.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Insmed Incorporated’s 10-Q dated March 31, 2026. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

Insmed Incorporated proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).

Cite this page

Proxy Votes Now, “Insmed (INSM) 2026 Annual Meeting: Vote Results & How Funds Voted”, https://proxyvotesnow.com/company/insmed-incorporated/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.